Biological
Vaccines, Combined clinical trials
- studies test it
- 6
- open now
- 2
- in phase 3
- 2
- first study started
- 2009
Keep track of what changes. Save the Vaccines, Combined studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
6 studies that test it; most in 2025 (2)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2025 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 3
- Phase 3
- 2
- Phase 4
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 3
PATH (1) · LG Chem (1) · Tanabe Pharma Corporation (1) · Instituto Nacional de Salud Publica, Mexico (1) · Serum Institute of India Pvt. Ltd. (1) · International Centre for Diarrhoeal Disease Research, Bangladesh (1)
Often tested with
Tested in the same studies.
R21 (1) · Measles Vaccine (1) · Rubella Vaccine (1) · Yellow Fever Vaccine (1) · Typhoid-Paratyphoid Vaccines (1) · Poliovirus Vaccine, Inactivated (1)
Studies
Open first, then newest update. How each study uses Vaccines, Combined is read from its arms, and is right about nine times in ten.
Testing it · 6
- Safety and Immunogenicity of a Combined Diphtheria, Tetanus, Whole Cell Pertussis, Hepatitis B, Recombinant Poliomyelitis and Haemophilus Influenzae Type b (Hib) Vaccine (SIIPL DTwP-HepB-rPV-Hib)Not yet recruitingPhase 1/2Serum Institute of India Pvt. Ltd.NCT07855172Written as Hexavalent (DTwP-HepB-rPV-Hib) Vaccine
- Immunogenicity of Different Primary Immunization Schedules with Inactivated Poliovirus Vaccine (IPV) Plus Pentavalent Vaccine (DTwP-HBV-Hib) or with Hexavalent Vaccine (DTwP-HBV-Hib-IPV)Not yet recruitingPhase 4International Centre for Diarrhoeal Disease Research, BangladeshNCT06748612Written as Pentavalent vaccine
- Infant Malaria Vaccine Schedule OptimizationActive, not recruitingPhase 2PATHNCT06879327Written as Hexavalent Vaccine
- Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary SeriesCompletedPhase 2/3LG ChemNCT05457946Written as LBVD (Hexavalent vaccine)
- Safety and Efficacy of BK1310 Intramuscular Injection in Healthy InfantsCompletedPhase 3Tanabe Pharma CorporationNCT03188692Written as DPT-IPV-Hib (Combined Vaccine)
- Evaluation of Immunogenicity Levels in Women With HPV Vaccine in MexicoCompletedPhase 4Instituto Nacional de Salud Publica, MexicoNCT01717118Written as Bivalent Vaccines